For the 5 tests, the cumulative probabilities of very abnormal laboratory results varied from 0.2% for leukocyte count to 6.6% for eGFR at 2 years and from 0.3 to 11%, respectively, at 5 years.

Please provide your email address to receive an email when new articles are posted on . Medicare will begin offering coverage for PrismRA, a molecular diagnostic test that predicts treatment response ...

Thus far, the promise of precision medicine has been directed largely toward the field of oncology in terms of recommending personalized treatments based on molecular diagnostics tests. But ...

When persistent joint pain strikes, the search for answers often leads to a crucial diagnostic tool: the rheumatoid factor test. This relatively quick blood analysis serves as a window into the immune ...

Seven years ago, Northeastern graduate Susan Dina Ghiassian was the first employee of Scipher Medicine Corp., a precision medicine company co-founded by Northeastern professor Albert-László Barabási.

Augurex expands its 14-3-3eta test availability through a new partnership with Sonic Reference Laboratory, a division of Sonic Healthcare USA, to enhance the diagnosis and management of rheumatoid ...